Contact Us
Drug Search Results
Using advanced filters...
Advanced Search [+]

Levosulpiride

Alternative Names: levosulpiride
Latest Update: 2024-12-06
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: D2 Blocker

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral,Intramuscular

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Brazil | Bulgaria | Chile | Colombia | Cyprus | Dominican Republic | Ecuador | Egypt | India | Italy | Korea | Lebanon | Malta | Mexico | Pakistan | Peru | Portugal | Romania | Saudi Arabia | Spain | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Carmen Clapp
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Schizophrenia|Psychomotor Agitation

Phase 2: Dyspepsia|Diabetic Retinopathy|Schizophrenia|Macular Edema|Depressive Disorder

Phase 1: Anorexia|Constipation|Chronic Pain|Migraine Disorders|Visceral Pain|Headache Disorders, Primary|Depressive Disorder|Gastroparesis|Heartburn|Schizophrenia|Abdominal Pain|Sensation Disorders|Acute Pain|Hemiplegia|Diarrhea|Dyspepsia

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
LDRDME_247164

P2

Recruiting

Macular Edema|Diabetic Retinopathy

2025-12-01

EC/07/17/1202

N/A

Completed

Helicobacter Infections|Dyspepsia

2019-05-31

CTR20181791

N/A

Completed

Healthy Volunteers

2018-09-04

CTR20132118

P2

Completed

Unknown

2015-03-12

CTR20150181

P2

Completed

Dyspepsia

2014-02-25

CTR20131994

P1

Completed

Chronic Pain|Abdominal Pain|Diarrhea|Schizophrenia|Migraine Disorders|Visceral Pain|Anorexia|Heartburn|Headache Disorders, Primary|Hemiplegia|Constipation|Depressive Disorder|Acute Pain|Gastroparesis|Sensation Disorders

2014-02-07

WHXH-Levosul

P1

Completed

Dyspepsia

2013-05-01

2004L03556

P3

Completed

Psychomotor Agitation|Schizophrenia

2010-07-01

CTR20160303

P2

Not yet recruiting

Schizophrenia|Depressive Disorder

None

Recent News Events

Date

Type

Title

03/20/2024

PubMed

 Dopaminergic Drugs and Valproate-associated Refractory Hyponatremia Over Levosulpiride-induced Parkinsonism in an Elderly Female Patient When Deprescribing was the Only Therapy.

01/01/2024

PubMed

 Fixed drug combination (levosulpiride and rabeprazole)-induced atypical Parkinsonian's disorders with associated anxiety and low-lying depression.

09/02/2023

News Article

 The Levosulpiride market report's foreign opportunities and dynamics analysis delves into the market's size, which is projected to grow at a CAGR of 8.5% from 2023 to 2030, and provides an overview of revenue generation, COVID-19 impact, and application.

09/02/2023

News Article

 Strontium Chloride Hexahydrate Market Trends identifies the leading companies and provides analysis of key factors influencing t 4% CAGR Forecasted from 2023 to 2030

09/02/2023

News Article

 This report provides a comprehensive analysis of the Cancer Pain market's current state and future growth potential, with a projected CAGR of 4.4% over the forecast period 2023 to 2030.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions